Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Julphar
Colorcon
Covington
Citi

Generated: March 18, 2019

DrugPatentWatch Database Preview

DARZALEX Drug Profile

« Back to Dashboard

Summary for Tradename: DARZALEX
Patents:6
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for DARZALEX
Ingredient-typeAntibodies, Monoclonal
Mechanism of ActionCD38-directed Antibody Interactions

US Patents for DARZALEX

Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Janssen Biotech DARZALEX daratumumab INJECTABLE;INJECTION 761036 002 2015-11-16 ➤ Try a Free Trial ABBVIE STEMCENTRX LLC (North Chicago, IL) ➤ Try a Free Trial RX Orphan search
Janssen Biotech DARZALEX daratumumab INJECTABLE;INJECTION 761036 002 2015-11-16 ➤ Try a Free Trial Excelse Bio, Inc. (Thousand Oaks, CA) ➤ Try a Free Trial RX Orphan search
Janssen Biotech DARZALEX daratumumab INJECTABLE;INJECTION 761036 002 2015-11-16 ➤ Try a Free Trial Mayo Foundation for Medical Education and Research (Rochester, MN) ➤ Try a Free Trial RX Orphan search
Janssen Biotech DARZALEX daratumumab INJECTABLE;INJECTION 761036 002 2015-11-16 ➤ Try a Free Trial The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) Janssen Biotech, Inc. (Spring House, PA) ➤ Try a Free Trial RX Orphan search
Janssen Biotech DARZALEX daratumumab INJECTABLE;INJECTION 761036 002 2015-11-16 ➤ Try a Free Trial Advenchen Pharmaceuticals, LLC (Moorpark, CA) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Accenture
Merck
Federal Trade Commission
Fuji
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: